... Releases-2007 Orchid receives US FDA approval for Cefpodoxime Proxetil ANDA Orchid ’ s Q2 FY08 revenue higher by 20 %at Rs 295 crore Net profit jumps 115 %to Rs 63 crore Orchid ’ s Managing Director honoured with Doctorate by leading university Orchid receives US FDA approval for its Cefdinir ANDAs Receives approval in about 12-months from filing Orchid ’ s Q1 FY 2007-08 net profit surges by 252 %to Rs 51 crore Key product launches in the US market and foreign exchange gains drive strong profits Orchid receives US FDA approval for its Cefepime ANDA Orchid forays into the non-antibiotic generic formulations segment Receives tentative approval from US FDA for Terbinafine HCL Tablets ANDA Orchid ’ s turnover rises to Rs 934 crore during FY 2006-07 Net profit increases to Rs 97 crore Orchid ’ s drug discovery subsidiary (Orchid Research Labs) awarded Partner of Choice award by Frost & Sullivan Orchid to foray into the Canadian generic formulations market Receives Canadian TPD approval for two generic formulations Orchid raises USD 200 million by way of zero coupon FCCBs Orchid in a new licensing and distribution alliance with Actavis to market cephalosporin ...

... 127 crs surges by 23 %UK MHRA (UK MCA) approval received for Unit 3 Subscription to preferential issue of equity shares Aurobindo Q3 PAT grows by 68 %Exports soar to 51 %of sales Aurobindo gets its first CoS approval from EDQM & files DMF for Citalopram Aurobindo's Q2 Net Profit jumps to Rs.321.5 million, spurt by 57 %Preferential Issue of Equity Shares Aurobindo net profit spurts by 52.75 %in Q1 Aurobindo crosses the landmark Net Profit of Rs.100 crores Aurobindo's demonstration of R & D leadership in cephalosporins Aurobindo Pharma launches cefepime Second quarter profit jumps 41.13 %Aurobindo implementing ERP package First quarter profit jumps 34 %Aurobindo posts Net Profit of Rs. 68.51 crores Noted Cardiologist Dr. I. Satyamurthy joins Aurobindo Board Aurobindo Pharma wins award for the best bulk drug company Shares allotted to Templeton Brazilian GMP certification received for the speciality generic formulations unit Aurobindo Pharma acquires equity in Ranit Pharma Mr. Lanka Srinivas inducted as Additional Director on Board of Aurobindo Pharma Aurobindo Pharma launches Aztreonam for the first time in India Aurobindo Pharma & Citadel promote a joint venture Aurobindo Pharma welcomes ...